全文获取类型
收费全文 | 304篇 |
免费 | 31篇 |
专业分类
335篇 |
出版年
2021年 | 6篇 |
2019年 | 3篇 |
2018年 | 2篇 |
2017年 | 3篇 |
2016年 | 7篇 |
2015年 | 5篇 |
2014年 | 10篇 |
2013年 | 17篇 |
2012年 | 17篇 |
2011年 | 12篇 |
2010年 | 16篇 |
2009年 | 6篇 |
2008年 | 20篇 |
2007年 | 15篇 |
2006年 | 11篇 |
2005年 | 10篇 |
2004年 | 16篇 |
2003年 | 11篇 |
2002年 | 8篇 |
2001年 | 10篇 |
2000年 | 16篇 |
1999年 | 10篇 |
1998年 | 3篇 |
1997年 | 4篇 |
1994年 | 3篇 |
1993年 | 2篇 |
1992年 | 9篇 |
1991年 | 6篇 |
1990年 | 7篇 |
1989年 | 7篇 |
1988年 | 4篇 |
1987年 | 4篇 |
1986年 | 4篇 |
1985年 | 2篇 |
1984年 | 5篇 |
1983年 | 2篇 |
1981年 | 3篇 |
1980年 | 3篇 |
1976年 | 2篇 |
1973年 | 2篇 |
1972年 | 1篇 |
1971年 | 2篇 |
1970年 | 2篇 |
1969年 | 3篇 |
1968年 | 4篇 |
1967年 | 3篇 |
1966年 | 4篇 |
1965年 | 1篇 |
1962年 | 1篇 |
1961年 | 2篇 |
排序方式: 共有335条查询结果,搜索用时 0 毫秒
161.
Daneault V Vandewalle G Hébert M Teikari P Mure LS Doyon J Gronfier C Cooper HM Dumont M Carrier J 《Journal of biological rhythms》2012,27(3):257-264
Many nonvisual functions are regulated by light through a photoreceptive system involving melanopsin-expressing retinal ganglion cells that are maximally sensitive to blue light. Several studies have suggested that the ability of light to modulate circadian entrainment and to induce acute effects on melatonin secretion, subjective alertness, and gene expression decreases during aging, particularly for blue light. This could contribute to the documented changes in sleep and circadian regulatory processes with aging. However, age-related modification in the impact of light on steady-state pupil constriction, which regulates the amount of light reaching the retina, is not demonstrated. We measured pupil size in 16 young (22.8±4 years) and 14 older (61±4.4 years) healthy subjects during 45-second exposures to blue (480 nm) and green (550 nm) monochromatic lights at low (7×10(12) photons/cm2/s), medium (3×10(13) photons/cm2/s), and high (10(14) photons/cm2/s) irradiance levels. Results showed that young subjects had consistently larger pupils than older subjects for dark adaptation and during all light exposures. Steady-state pupil constriction was greater under blue than green light exposure in both age groups and increased with increasing irradiance. Surprisingly, when expressed in relation to baseline pupil size, no significant age-related differences were observed in pupil constriction. The observed reduction in pupil size in older individuals, both in darkness and during light exposure, may reduce retinal illumination and consequently affect nonvisual responses to light. The absence of a significant difference between age groups for relative steady-state pupil constriction suggests that other factors such as tonic, sympathetic control of pupil dilation, rather than light sensitivity per se, account for the observed age difference in pupil size regulation. Compared to other nonvisual functions, the light sensitivity of steady-state pupil constriction appears to remain relatively intact and is not profoundly altered by age. 相似文献
162.
163.
Summary This paper reports on the measurement of NAD(P)H dependent culture fluorescence during the batch culture of Methylomonas mucosa, a potential polysaccharide producer. The results obtained reveal that there is a high correlation between the fluorescence level and the cell concentration. The logistic equation was also found to be applicable for representing the biomass concentration data during the course of fermentation. A model was then presented for predicting both the biomass concentration and the culture fluorescence with high fidelity. 相似文献
164.
165.
The chicken nerve growth factor (beta NGF) gene has been mapped by fluorescent in situ hybridization to a pair of microchromosomes, confirming previous reports of the existence of a single gene locus. A 39-kb genomic fragment cloned in a cosmid vector and including the 5' end of the beta NGF locus was biotinylated for nonradioactive detection of the gene. This report adds to the increasing evidence proving microchromosomal localization of highly conserved and biologically fundamental genes. The implications of such genes belonging to very small linkage groups for the transmission of alleles from generation to generation together with the relevance of nonisotopic in situ hybridization for avian gene mapping are considered. 相似文献
166.
Bahrudin U Morisaki H Morisaki T Ninomiya H Higaki K Nanba E Igawa O Takashima S Mizuta E Miake J Yamamoto Y Shirayoshi Y Kitakaze M Carrier L Hisatome I 《Journal of molecular biology》2008,384(4):896-907
The ubiquitin-proteasome system is responsible for the disappearance of truncated cardiac myosin-binding protein C, and the suppression of its activity contributes to cardiac dysfunction. This study investigated whether missense cardiac myosin-binding protein C gene (MYBPC3) mutation in hypertrophic cardiomyopathy (HCM) leads to destabilization of its protein, causes UPS impairment, and is associated with cardiac dysfunction. Mutations were identified in Japanese HCM patients using denaturing HPLC and sequencing. Heterologous expression was investigated in COS-7 cells as well as neonatal rat cardiac myocytes to examine protein stability and proteasome activity. The cardiac function was measured using echocardiography. Five novel MYBPC3 mutations—E344K, ΔK814, Δ2864-2865GC, Q998E, and T1046M—were identified in this study. Compared with the wild type and other mutations, the E334K protein level was significantly lower, it was degraded faster, it had a higher level of polyubiquination, and increased in cells pretreated with the proteasome inhibitor MG132 (50 μM, 6 h). The electrical charge of its amino acid at position 334 influenced its stability, but E334K did not affect its phosphorylation. The E334K protein reduced cellular 20 S proteasome activity, increased the proapoptotic/antiapoptotic protein ratio, and enhanced apoptosis in transfected Cos-7 cells and neonatal rat cardiac myocytes. Patients carrying the E334K mutation presented significant left ventricular dysfunction and dilation. The conclusion is the missense MYBPC3 mutation E334K destabilizes its protein through UPS and may contribute to cardiac dysfunction in HCM through impairment of the ubiquitin-proteasome system. 相似文献
167.
Mark W. Ledeboer Albert C. Pierce John P. Duffy Huai Gao David Messersmith Francesco G. Salituro Suganthini Nanthakumar Jon Come Harmon J. Zuccola Lora Swenson Dina Shlyakter Sudipta Mahajan Thomas Hoock Bin Fan Wan-Jung Tsai Elaine Kolaczkowski Scott Carrier James K. Hogan Richard Zessis S. Pazhanisamy Youssef L. Bennani 《Bioorganic & medicinal chemistry letters》2009,19(23):6529-6533
Constitutive activation of the EPO/JAK2 signaling cascade has recently been implicated in a variety of myeloproliferative disorders including polycythemia vera, essential thrombocythemia and myelofibrosis. In an effort to uncover therapeutic potential of blocking the EPO/JAK2 signaling cascade, we sought to discover selective inhibitors that block the kinase activity of JAK2. Herein, we describe the discovery and structure based optimization of a novel series of 2-amino-pyrazolo[1,5-a]pyrimidines that exhibit potent inhibition of JAK2. 相似文献
168.
Background
The process of translation occurs at a nexus point downstream of a number of signal pathways and developmental processes. Modeling activation of the PTEN/AKT/mTOR pathway in the Eμ-Myc mouse is a valuable tool to study tumor genotype/chemosensitivity relationships in vivo. In this model, blocking translation initiation with silvestrol, an inhibitor of the ribosome recruitment step has been showed to modulate the sensitivity of the tumors to the effect of standard chemotherapy. However, inhibitors of translation elongation have been tested as potential anti-cancer therapeutic agents in vitro, but have not been extensively tested in genetically well-defined mouse tumor models or for potential synergy with standard of care agents.Methodology/Principal Findings
Here, we chose four structurally different chemical inhibitors of translation elongation: homoharringtonine, bruceantin, didemnin B and cycloheximide, and tested their ability to alter the chemoresistance of Eμ-myc lymphomas harbouring lesions in Pten, Tsc2, Bcl-2, or eIF4E. We show that in some genetic settings, translation elongation inhibitors are able to synergize with doxorubicin by reinstating an apoptotic program in tumor cells. We attribute this effect to a reduction in levels of pro-oncogenic or pro-survival proteins having short half-lives, like Mcl-1, cyclin D1 or c-Myc. Using lymphomas cells grown ex vivo we reproduced the synergy observed in mice between chemotherapy and elongation inhibition and show that this is reversed by blocking protein degradation with a proteasome inhibitor.Conclusion/Significance
Our results indicate that depleting short-lived pro-survival factors by inhibiting their synthesis could achieve a therapeutic response in tumors harboring PTEN/AKT/mTOR pathway mutations. 相似文献169.
Eijssen LM van den Bosch BJ Vignier N Lindsey PJ van den Burg CM Carrier L Doevendans PA van der Vusse GJ Smeets HJ 《Genomics》2008,91(1):52-60
Familial hypertrophic cardiomyopathy (FHC) is an autosomal dominant disease characterized by left ventricular hypertrophy (LVH) predominantly affecting the interventricular septum. Cardiac myosin-binding protein C (cMyBP-C) mutations are common causes of FHC. Gene expression profiling was performed in left ventricles of 9-week-old wild-type mice, heterozygous cMyBP-C KO mice displaying asymmetric septal hypertrophy, and homozygous mice developing eccentric LVH. Knocking out one or two cMyBP-C genes leads primarily to gene expression changes indicating an increased energy demand, activation of the JNK and p38 parts of the MAPK pathway and deactivation of the ERK part, and induction of apoptosis. Altered gene expression for processes related to cardiac structure, contractile proteins, and protein turnover was also identified. Many of the changes were more pronounced in the homozygous KO mice. These alterations point to physiological and pathological adaptations in the prehypertrophic heterozygous KO mice and the hypertrophic homozygous mice. 相似文献
170.
C. Triby P. Carrier F. Peyrade N. Mounier X. Fontana J.-P. Chaborel L. Tessonnier D. Benisvy M. Razzouk F. Bussière J. Darcourt 《Médecine Nucléaire》2008,32(2):85-95
Zevalin® (yttrium-90 ibritumomab-tiuxetan) is the first radioimmunotherapy authorized in France for non-Hodgkin's lymphoma (NHL) treatment. It is indicated for clinical use in adults for recurrent or refractory follicular NHL including those refractory to rituximab. Treatment responses are between 70 and 80%. Since three years, 13 patients were treated in Nice by Zevalin®. From this retrospective study, we discuss the various perspectives of this treatment. The majority of our patients in this study were evaluated by 18-FDG–PET and we also evaluated our results in this regard. Even if our follow-up is short, our experience confirms the efficacy and tolerance of Zevalin® treatment in multirecurrent follicular NHL including those refractory to rituximab. The treatment is of interest in elderly patients and in case of autologous stem cell transplant. The proposed « Autorisation de Mise sur le Marché » (AMM) indication is probably not the best one since efficacy seems better in smaller tumour volumes and when used earlier in the therapeutic course. Zevalin® will probably be more beneficial in first line treatment, for immunochemotherapy consolidation and for autologous stem cell transplant conditioning. We pointed out the prognostic value of FDG–PET for early post-treatment evaluation, one to two months after Zevalin® administration. However, larger scale studies are necessary to confirm these findings. 相似文献